OBJECTIVE: to study possible interrelations existing between the Mini-Suffering State Examination (MSSE) scale and survival of end-stage dementia patients. METHODS: a cohort study of 252 end-stage dementia patients with a 6-month follow-up period, conducted in a Division of Geriatric Medicine of a general hospital. We included 134 consecutive bedridden end-stage dementia patients admitted during a 36-month period, and surviving in the ward for <6 months. Interrelations between survival and admission MSSE scores were studied. RESULTS: compared with patients surviving >/=6 months, those dying within 6 months were significantly older (P = 0.014). Mean survival time was 57.76 +/- 9.73 days for the low MSSE score group (29 patients, MSSE 2.24 +/- 0.99), 44.70 +/- 5.99 days for the intermediate MSSE score group (53 patients, MSSE 4.92 +/- 0.83) and 27.54 +/- 4.16 days for the high MSSE score group (52 patients, MSSE 8.06 +/- 1.00). Differences between the survival times of these three MSSE score groups were statistically significant (Kaplan-Meier Analysis Log Rank P = 0.0018, Breslow P = 0.0027). The Cox proportional hazard model of survival showed a significant interrelation of high MSSE scores and shorter survival (P = 0.013). CONCLUSIONS: documentation of a high-suffering level by the MSSE scale helps in identifying end-stage dementia patients expected to benefit from enrolment into a palliative care setting.
OBJECTIVE: to study possible interrelations existing between the Mini-Suffering State Examination (MSSE) scale and survival of end-stage dementiapatients. METHODS: a cohort study of 252 end-stage dementiapatients with a 6-month follow-up period, conducted in a Division of Geriatric Medicine of a general hospital. We included 134 consecutive bedridden end-stage dementiapatients admitted during a 36-month period, and surviving in the ward for <6 months. Interrelations between survival and admission MSSE scores were studied. RESULTS: compared with patients surviving >/=6 months, those dying within 6 months were significantly older (P = 0.014). Mean survival time was 57.76 +/- 9.73 days for the low MSSE score group (29 patients, MSSE 2.24 +/- 0.99), 44.70 +/- 5.99 days for the intermediate MSSE score group (53 patients, MSSE 4.92 +/- 0.83) and 27.54 +/- 4.16 days for the high MSSE score group (52 patients, MSSE 8.06 +/- 1.00). Differences between the survival times of these three MSSE score groups were statistically significant (Kaplan-Meier Analysis Log Rank P = 0.0018, Breslow P = 0.0027). The Cox proportional hazard model of survival showed a significant interrelation of high MSSE scores and shorter survival (P = 0.013). CONCLUSIONS: documentation of a high-suffering level by the MSSE scale helps in identifying end-stage dementiapatients expected to benefit from enrolment into a palliative care setting.
Authors: Susan L Mitchell; Betty S Black; Mary Ersek; Laura C Hanson; Susan C Miller; Greg A Sachs; Joan M Teno; R Sean Morrison Journal: Ann Intern Med Date: 2012-01-03 Impact factor: 25.391
Authors: Lauren H Nicholas; Julie P W Bynum; Theodore J Iwashyna; David R Weir; Kenneth M Langa Journal: Health Aff (Millwood) Date: 2014-04 Impact factor: 6.301
Authors: E J Byrne; M Benoit; J M Lopez Arrieta; C Geraldi; R Koopmans; Y Rolland; N Sartorius; G Stoppe; P Robert Journal: J Nutr Health Aging Date: 2008-12 Impact factor: 4.075
Authors: Marie-Paule E van Engelen; Flora T Gossink; Lieke S de Vijlder; Jan R A Meursing; Philip Scheltens; Annemiek Dols; Yolande A L Pijnenburg Journal: J Alzheimers Dis Date: 2020 Impact factor: 4.472